Biophytis Stock Current Ratio
BPTSDelisted Stock | USD 7.03 0.00 0.00% |
Biophytis fundamentals help investors to digest information that contributes to Biophytis' financial success or failures. It also enables traders to predict the movement of Biophytis Stock. The fundamental analysis module provides a way to measure Biophytis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biophytis stock.
Biophytis |
Biophytis Company Current Ratio Analysis
Biophytis' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Biophytis Current Ratio | 1.37 X |
Most of Biophytis' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biophytis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Biophytis has a Current Ratio of 1.37 times. This is 52.92% lower than that of the Biotechnology sector and 80.43% lower than that of the Health Care industry. The current ratio for all United States stocks is 36.57% higher than that of the company.
Biophytis Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biophytis' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics of similar companies.Biophytis is currently under evaluation in current ratio category among its peers.
Biophytis Fundamentals
Return On Equity | -12.44 | |||
Return On Asset | -0.53 | |||
Current Valuation | 9.73 B | |||
Shares Outstanding | 286.5 K | |||
Shares Owned By Institutions | 0.04 % | |||
Number Of Shares Shorted | 368.95 K | |||
Price To Book | 2.26 X | |||
EBITDA | (15.09 M) | |||
Net Income | (17.03 M) | |||
Cash And Equivalents | 23.93 M | |||
Cash Per Share | 1.71 X | |||
Total Debt | 8.27 M | |||
Debt To Equity | 3.27 % | |||
Current Ratio | 1.37 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (13.33 M) | |||
Short Ratio | 0.41 X | |||
Earnings Per Share | (128.39) X | |||
Target Price | 6000.0 | |||
Number Of Employees | 22 | |||
Beta | 1.05 | |||
Market Capitalization | 2.61 M | |||
Total Asset | 11.94 M | |||
Retained Earnings | (19.38 M) | |||
Working Capital | (3.52 M) | |||
Net Asset | 11.94 M |
About Biophytis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biophytis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stocks Directory Find actively traded stocks across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements |